Design Therapeutics, Inc. SEC filings

Filings

1. SCHEDULE 13G/ADesign Therapeutics, Inc.DSGNAug 14

   Ownership stake disclosure by Point72 Asset Management, L.P. (amended)

   Point72 Asset Management, L.P., filed by

2. SCHEDULE 13GDesign Therapeutics, Inc.DSGNAug 14

   Ownership stake disclosure by Sirenia Capital Management LP

   Sirenia Capital Management LP, filed by

3. 10-QDesign Therapeutics, Inc.DSGNAug 3

   Quarterly report

4. 8-KDesign Therapeutics, Inc.DSGNAug 3

   Current report

5. 4Design Therapeutics, Inc.DSGNJun 11

   6 insider filings

   Simeon George, insider filing for DSGN

   Show all 6

   • 4Insider filing for DSGNJun 11
   • 4Insider filing for DSGNJun 11
   • 4Insider filing for DSGNJun 11
   • 4Insider filing for DSGNJun 11
   • 4Insider filing for DSGNJun 11
   • 4Insider filing for DSGNJun 11

   Simeon George, reporting

6. 8-KDesign Therapeutics, Inc.DSGNJun 11

   Current report

7. SCHEDULE 13GDesign Therapeutics, Inc.DSGNJun 9

   Ownership stake disclosure by Point72 Asset Management, L.P.

   Point72 Asset Management, L.P., filed by

8. 8-KDesign Therapeutics, Inc.DSGNMay 18

   Current report

9. SCHEDULE 13G/ADesign Therapeutics, Inc.DSGNMay 15

   Ownership stake disclosure by Point72 Asset Management, L.P. (amended)

   Point72 Asset Management, L.P., filed by

10. 10-QDesign Therapeutics, Inc.DSGNApr 28

    Quarterly report

11. 8-KDesign Therapeutics, Inc.DSGNApr 28

    Current report

12. DEFA14ADesign Therapeutics, Inc.DSGNApr 23

    Additional proxy materials

13. DEF 14ADesign Therapeutics, Inc.DSGNApr 23

    Proxy statement

14. ARSDesign Therapeutics, Inc.DSGNApr 23

    Annual report to shareholders

15. 4Design Therapeutics, Inc.DSGNApr 1

    2 insider filings

    David Shapiro, insider filing for DSGN

    Show all 2

    • 4Insider filing for DSGNApr 1
    • 3New insider at DSGNApr 1

    David Shapiro, reporting

16. 8-KDesign Therapeutics, Inc.DSGNApr 1

    Current report

17. SCHEDULE 13D/ADesign Therapeutics, Inc.DSGNMar 11

    Ownership stake disclosure by SR One Capital Fund I Aggregator LP (amended)

    SR One Capital Fund I Aggregator LP, filed by

18. S-8Design Therapeutics, Inc.DSGNMar 9

    Employee stock plan registration

19. 10-KDesign Therapeutics, Inc.DSGNMar 9

    Annual report

20. 8-KDesign Therapeutics, Inc.DSGNMar 9

    Current report

21. SCHEDULE 13G/ADesign Therapeutics, Inc.DSGNFeb 17

    Ownership stake disclosure by Point72 Asset Management, L.P. (amended)

    Point72 Asset Management, L.P., filed by

22. 8-KDesign Therapeutics, Inc.DSGNJan 30

    Current report

23. 4Design Therapeutics, Inc.DSGNJan 5

    5 insider filings

    Chris Storgard, insider filing for DSGN

    Show all 5

    • 4Insider filing for DSGNJan 5
    • 4Insider filing for DSGNJan 5
    • 4Insider filing for DSGNJan 5
    • 4Insider filing for DSGNJan 5
    • 4Insider filing for DSGNJan 5

    Chris Storgard, reporting

24. 4Design Therapeutics, Inc.DSGNDec 11, 2025

    Pratik Shah, insider filing for DSGN

    Pratik Shah, reporting

25. SCHEDULE 13D/ADesign Therapeutics, Inc.DSGNNov 19, 2025

    Design Therapeutics, Inc. filed SCHEDULE 13D/A

    • Form Type: SCHEDULE 13D/A
    • Filing Date: 2025-11-18

    Logos Global Management LP, filed by

26. 144Design Therapeutics, Inc.DSGNNov 14, 2025

    Logos Global Master Fund LP, planned sale of DSGN shares

    Logos Global Master Fund LP, reporting

27. SCHEDULE 13D/ADesign Therapeutics, Inc.DSGNNov 12, 2025

    Ownership stake disclosure by Logos Global Management LP (amended)

    Logos Global Management LP, filed by

28. 144Design Therapeutics, Inc.DSGNNov 7, 2025

    Logos Global Master Fund LP, planned sale of DSGN shares

    Logos Global Master Fund LP, reporting

29. 10-QDesign Therapeutics, Inc.DSGNNov 5, 2025

    Quarterly report

30. 8-KDesign Therapeutics, Inc.DSGNNov 5, 2025

    Current report

Older filings on EDGAR